Skip to content

AARD AARD Free cash flow yield

Free cash flow yield at other companies

AbbVie logo
AbbVieABBV
5.2%+1.0pp
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-1.6%-0.5pp
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-8.7%-2.9pp
Arvinas logo
ArvinasARVN
-37.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-12.1%-4.1pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-18.1%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

Based on trailing twelve months.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's free cash flow yield?
AARD (AARD) reported free cash flow yield of -19% in Q4 2025.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.